ropinirole
ropinirole is listed in the FDA National Drug Code directory with 39 NDC codes, marketed under brand names including ropinirole, ROPINIROLE, Ropinirole. Available dosage forms: tablet, film coated, tablet, extended release.
Drug details
- Generic Name
- ropinirole
- Brand Names
- ropinirole, ROPINIROLE, Ropinirole
- Application Number
- ANDA090135
- Sponsor
- Glenmark Pharmaceuticals Inc., USA
- NDC Codes
- 39
- Dosage Forms
- TABLET, FILM COATED, TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Active Ingredients
- ROPINIROLE HYDROCHLORIDE, ROPINIROLE
Indications and Usage
1 INDICATIONS AND USAGE Ropinirole tablets are a non-ergoline dopamine agonist indicated for the treatment of Parkinson’s disease (PD) and moderate-to-severe primary Restless Legs Syndrome (RLS). (1.1, 1.2) 1.1 Parkinson’s Disease Ropinirole tablets are indicated for the treatment of Parkinson’s disease. 1.2 Restless Legs Syndrome Ropinirole tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).